Rep. Tom Kean Jr. has not cast a single vote in Congress since March 5. He has offered no public explanation for his absence beyond vague assurances of a "full recovery." His constituents in New Jersey's Seventh District have been left to wonder where their representative went and why. But financial disclosure records show that while Kean was nowhere near Capitol Hill, he was busy buying and selling stocks.
Between March 10 and March 31, Kean purchased and sold shares of eight different companies, including Johnson & Johnson, Amcor, Chubb Limited, and First Citizens BancShares, with a combined trade value ranging from $50,008 to $190,000, the Daily Caller News Foundation reported. He personally certified the disclosure and signed it with his digital signature on April 13.
That timeline matters. Kean was well enough to execute stock trades and sign official documents, but not well enough to show up for the job voters sent him to do.
Kean's office did not respond to the Daily Caller News Foundation's request for comment. His only public statement, relayed through the New Jersey Globe, was that he "expects to return to Capitol Hill for roll call votes soon" and is "expected to make a full recovery and will discuss his health at a later date."
That non-answer has been the pattern for more than two months. Kean's extended disappearance from Congress has drawn increasing scrutiny, and the stock-trading disclosure adds a new dimension to the questions surrounding his absence.
GovTrack data shows Kean missed 20 percent of House votes between January and March 2026, and has missed every single roll call vote since March 5. That is not a brief leave. That is a prolonged abandonment of duty with no transparency.
The stock trades are not the only evidence that Kean remained active behind the scenes while absent from the House floor. He signed at least two documents on March 13 and March 14 approving travel for his chief of staff, Daniel J. Scharfenberger. Those approvals, obtained by NOTUS and published alongside the financial disclosures, show Kean engaging in routine office functions during the same window he was supposedly too incapacitated to vote.
So the congressman could manage his stock portfolio. He could approve staff travel. He could digitally sign federal disclosure forms. He just couldn't cast votes on behalf of the roughly 760,000 people in his district.
The Washington Examiner flagged the same pattern, noting Kean's stock activity despite his monthslong absence from the House. The contrast between his private financial activity and his public silence speaks for itself.
There is another layer to this. When Kean first entered Congress after defeating Democratic Rep. Tom Malinowski in 2022, he pledged to place millions of dollars in personal assets into a congressionally approved blind trust. NOTUS reported that he never followed through on that pledge.
That broken promise carries extra weight given the circumstances. Kean ran partly on a platform of financial transparency, Malinowski had faced backlash for stock disclosure violations under the STOCK Act. Kean even sponsors bipartisan legislation to ban members of Congress from short-selling stocks.
Sponsoring ethics legislation while failing to honor your own transparency pledge is the kind of gap between words and actions that erodes public trust. It doesn't matter which party you belong to. Voters expect follow-through, not posturing.
Questions about how Republican leadership handles sensitive situations involving GOP members have surfaced repeatedly this Congress. Kean's case adds another example where silence from leadership has done nothing to resolve legitimate constituent concerns.
Kean represents a district that leans slightly Democratic in voter registration. Four Democrats are competing in a June 2 primary for the right to challenge him. His prolonged absence hands those challengers an obvious line of attack, and the stock-trading disclosure sharpens it considerably.
Local Republican leaders have tried to project calm. Union County Republican chair Carlos Santos said Kean "sounded good" during a recent phone call. Somerset County GOP chair Tracy DiFrancesco described him as "perfectly fine" and said he "should return to the campaign trail in the near future." Kean's reelection consultant, Harrison Neely, told Politico that "of course" the congressman would run again.
But reassurances from party insiders are no substitute for a public accounting from the congressman himself. Voters are not obligated to take "he sounded good on the phone" as a sufficient explanation for a two-month absence from the people's House.
The situation echoes broader concerns about House Republicans going missing at a time when the GOP majority is thin and every vote counts. Leadership has faced mounting pressure to address member absences and conduct, and the questions are not going away.
This is not about illness. If Kean is dealing with a serious health matter, he deserves compassion and privacy to the extent any private citizen would. But Tom Kean Jr. is not a private citizen. He is a sitting member of Congress drawing a taxpayer-funded salary, holding a seat in a closely divided House, and representing constituents who have a right to know whether their representative can do the job.
The stock-trading disclosure transforms the story. It is one thing to step away from public life to recover from an illness. It is another to remain active enough to manage a six-figure stock portfolio and sign official documents while telling the public nothing about when, or whether, you'll return to your actual duties.
Republicans rightly demand accountability from the other side of the aisle. They hammered Democrats over absenteeism, proxy voting, and members who were clearly unable to serve. The same standard has to apply here. Accountability that only runs in one direction isn't accountability at all.
Speaker Johnson has faced questions about how he handles conduct issues within his own caucus before. Kean's case is different in kind, but the leadership principle is the same: constituents deserve answers, and silence is not a strategy.
Several questions remain unanswered. What is the nature of Kean's illness? When will he return? Why did he break his pledge to establish a blind trust? Does his stock trading during a period of absence raise any ethical concerns under House rules or the STOCK Act? And why has his office stonewalled press inquiries?
None of those questions are unfair. All of them are the kind that any elected official, Republican or Democrat, should expect to face after disappearing for two months while continuing to trade stocks and sign documents.
Kean won his seat by holding his opponent to a standard of financial transparency. His constituents are entitled to hold him to the same one.
A congressman who can't show up to vote but can show up to trade stocks isn't missing in action. He's missing in accountability.
